As demonstrated in Table 2, HR/HER2 triple negative, poor differentiation grade, advanced TNM stage, and the lack of radiotherapy or surgery were significant risk factors associated with the subsequent malignancies after first primary BC. This evidence concerns the gene ERBB2 and breast cancer.